前往化源商城

3-氧代-3-(3-吡啶基)丙酸乙酯

更新时间:2025-08-25 14:23:10

3-氧代-3-(3-吡啶基)丙酸乙酯结构式
3-氧代-3-(3-吡啶基)丙酸乙酯结构式
品牌特惠专场
常用名 3-氧代-3-(3-吡啶基)丙酸乙酯 英文名 3-Oxo-3-pyridin-3-yl-propionic acid ethyl ester
CAS号 6283-81-4 分子量 193.199
密度 1.2±0.1 g/cm3 沸点 298.0±15.0 °C at 760 mmHg
分子式 C10H11NO3 熔点 N/A
MSDS N/A 闪点 134.1±20.4 °C

 3-氧代-3-(3-吡啶基)丙酸乙酯名称

中文名 3-氧代-3-(3-吡啶基)丙酸乙酯
英文名 Ethyl 3-oxo-3-(pyridin-3-yl)propanoate
英文别名 更多

 3-氧代-3-(3-吡啶基)丙酸乙酯物理化学性质

密度 1.2±0.1 g/cm3
沸点 298.0±15.0 °C at 760 mmHg
分子式 C10H11NO3
分子量 193.199
闪点 134.1±20.4 °C
精确质量 193.073898
PSA 56.26000
LogP 0.68
InChIKey APQGYFNHIWMRIJ-UHFFFAOYSA-N
SMILES CCOC(=O)CC(=O)c1cccnc1
蒸汽压 0.0±0.6 mmHg at 25°C
折射率 1.511
储存条件 室温

 3-氧代-3-(3-吡啶基)丙酸乙酯安全信息

危害码 (欧洲) Xi
海关编码 2933399090

 3-氧代-3-(3-吡啶基)丙酸乙酯合成线路

~50%

3-氧代-3-(3-吡啶基)丙酸乙酯结构式

3-氧代-3-(3-吡啶基)丙酸乙酯

6283-81-4

文献:Bayer Healthcare AG Patent: WO2004/29055 A1, 2004 ; Location in patent: Page 52-53 ; WO 2004/029055 A1

~93%

3-氧代-3-(3-吡啶基)丙酸乙酯结构式

3-氧代-3-(3-吡啶基)丙酸乙酯

6283-81-4

文献:Venkat Ragavan; Vijayakumar; Rajesh; Palakshi Reddy; Karthikeyan; Suchetha Kumari Bioorganic and Medicinal Chemistry Letters, 2012 , vol. 22, # 12 p. 4193 - 4197

~25%

3-氧代-3-(3-吡啶基)丙酸乙酯结构式

3-氧代-3-(3-吡啶基)丙酸乙酯

6283-81-4

文献:Hoffmann-La Roche Inc.; Bhagirath, Niala; Brameld, Kenneth Albert; Kennedy-Smith, Joshua Patent: US2013/90333 A1, 2013 ; Location in patent: Paragraph 0130 ;

~53%

3-氧代-3-(3-吡啶基)丙酸乙酯结构式

3-氧代-3-(3-吡啶基)丙酸乙酯

6283-81-4

文献:Li, Francine Feirong; Rehder, Kenneth S.; Campbell, Michael Gordon; Viscardi, Celeste Patrice; Strachan, Jon-Paul; Guo, Zhengming Patent: US2004/116425 A1, 2004 ; Location in patent: Page 86 ;

~%

3-氧代-3-(3-吡啶基)丙酸乙酯结构式

3-氧代-3-(3-吡啶基)丙酸乙酯

6283-81-4

文献:WO2012/67664 A1, ; Page/Page column 28-29 ;

~%

3-氧代-3-(3-吡啶基)丙酸乙酯结构式

3-氧代-3-(3-吡啶基)丙酸乙酯

6283-81-4

文献:EP1156045 A1, ;

~41%

3-氧代-3-(3-吡啶基)丙酸乙酯结构式

3-氧代-3-(3-吡啶基)丙酸乙酯

6283-81-4

文献:Korsager, Signe; Nielsen, Dennis U.; Taaning, Rolf H.; Skrydstrup, Troels Angewandte Chemie - International Edition, 2013 , vol. 52, # 37 p. 9763 - 9766 Angew. Chem., 2013 , vol. 125, # 37 p. 9945 - 9948

~%

3-氧代-3-(3-吡啶基)丙酸乙酯结构式

3-氧代-3-(3-吡啶基)丙酸乙酯

6283-81-4

文献:Journal of the American Chemical Society, , vol. 70, p. 2755,2757

~%

3-氧代-3-(3-吡啶基)丙酸乙酯结构式

3-氧代-3-(3-吡啶基)丙酸乙酯

6283-81-4

文献:Pharmaceutical Bulletin, , vol. 3, p. 32

 3-氧代-3-(3-吡啶基)丙酸乙酯海关

海关编码 2933399090
中文概述 2933399090. 其他结构含非稠合吡啶环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%
申报要素 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期
Summary 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

 3-氧代-3-(3-吡啶基)丙酸乙酯靶点实验

查看更多实验

实验名称:Cytotoxicity against human HCT116 cells at 10 uM after 48 hrs by WST-1 assay
来源:ChEMBL
靶标:HCT-116
External Id:CHEMBL2038772
实验名称:Cytotoxicity against human ACHN cells at 10 uM after 48 hrs by WST-1 assay
来源:ChEMBL
靶标:ACHN
External Id:CHEMBL2038773
实验名称:Cytotoxicity against human NCI-H460 cells at 10 uM after 48 hrs by WST-1 assay
来源:ChEMBL
靶标:NCI-H460
External Id:CHEMBL2038771
实验名称:Cytotoxicity against human Calu1 cells at 10 uM after 48 hrs by WST-1 assay
来源:ChEMBL
靶标:Calu-1
External Id:CHEMBL2038774
实验名称:Cytotoxicity against human PANC1 cells at 10 uM after 48 hrs by WST-1 assay
来源:ChEMBL
靶标:PANC-1
External Id:CHEMBL2038775
实验名称:NCI human tumor cell line growth inhibition assay. Data for the MCF7 Non-Small Cell L...
来源:DTP/NCI
靶标:N/A
External Id:MCF7_OneDose
实验名称:NCI human tumor cell line growth inhibition assay. Data for the IGROV1 Non-Small Cell...
来源:DTP/NCI
靶标:N/A
External Id:IGROV1_OneDose
共7条,当前第1页,共1页
1

 3-氧代-3-(3-吡啶基)丙酸乙酯英文别名

ethyl 3-oxo-3-pyridin-3-ylpropanoate
ethyl 3-oxo-3-(pyridin-3-yl)propanoate
3-Pyridinepropanoic acid, β-oxo-, ethyl ester
Ethyl 3-oxo-3-(3-pyridinyl)propanoate
3-Oxo-3-pyridin-3-yl-propionic acid ethyl ester
本网页内容来自不同专业数据源,如对内容有疑义,欢迎联系service1@chemsrc.com。
品牌现货直购
推荐供应商:


查看所有供应商和价格请点击:

3-氧代-3-(3-吡啶基)丙酸乙酯生产厂家

3-氧代-3-(3-吡啶基)丙酸乙酯价格

相关化合物: 更多...
4-({[Bis(4-fluorophenyl)methyl]silyl}methyl)-4H-1,2,4-triazole
778531-64-9
3-[3-(2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,9-Heptadecafluorononanoylamino)propyl-dimethylazaniumyl]propanoate
119131-05-4
Bis(octahydro-1,4,7-trimethyl-1H-1,4,7-triazonine-kappaN1,kappaN4,kappaN7)tri-mu-oxodimanganese(2+)
116633-51-3
Ferrate(1-), bis[4-[2-[5-(1,1-dimethylethyl)-2-(hydroxy-kappaO)phenyl]diazenyl-kappaN1]-3-(hydroxy-kappaO)-N-phenyl-2-naphthalenecarboxamidato(2-)]-, sodium (1:1)
960154-36-3
Ferrate(1-), bis(4-(2-(5-chloro-2-(hydroxy-kappaO)phenyl)diazenyl-kappaN1)-2,4-dihydro-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)-kappaO3)-, hydrogen (1:1)
672925-74-5
Ferrate(1-a)a, bis[4-a[[5-achloro-a2-a(hydroxy-akappaO)aphenyl]aazo-akappaN1]a-a2,a4-adihydro-a5-amethyl-a2-aphenyl-a3H-apyrazol-a3-aonato(2-a)a-akappaO3]a
732244-72-3
(Z)-N-[(2S,3R,4R,5S,6R)-2-[(2R,3S,4R,5R,6S)-5-acetamido-6-[(2R,3S,4R,5R,6S)-5-acetamido-6-[(2R,3S,4R,5R,6S)-5-acetamido-6-[(2R,3S,4R,5R)-5-acetamido-1,2,4-trihydroxy-6-oxohexan-3-yl]oxy-4-hydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4-hydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4-hydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]octadec-11-enamide
168843-28-5
5-Acetamido-4-hydroxy-3-[(2-hydroxy-5-{[2-(sulfooxy)ethyl]sulfonyl}phenyl)diazenyl]-4a,8a-dihydro-2,7-naphthalenedisulfonic acid
1098339-23-1
Trisodium 5-acetamido-4-hydroxy-3-[(2-hydroxy-5-{[2-(sulfonatooxy)ethyl]sulfonyl}phenyl)diazenyl]-4a,8a-dihydro-2,7-naphthalenedisulfonate
1098165-12-8
Cobalt(3+) sodium 4-(3-methyl-4-((4-(((3-((3-methyl-5-oxo-1-phenyl-4,5-dihydro-1H-pyrazol-4-id-4-yl)diazenyl)-4-oxidophenyl)sulfonyl)amino)phenyl)diazenyl)-5-oxo-4,5-dihydro-1H-pyrazol-1-yl)benzenesulfonate (1:3:2)
75234-42-3